How AI is Changing Your Healthcare Experience
New AI tools may enhance how healthcare providers engage with patients, leading to more personalized care.
The whole archive, filed by the part of life it belongs to — and labelled with how strong the evidence behind it actually is.
Showing 1345–1368 of 3,535
New AI tools may enhance how healthcare providers engage with patients, leading to more personalized care.
The infection control market is set to grow significantly, improving safety in hospitals and reducing infection risks.
John Cena shares his experience with Demodex blepharitis, urging people to prioritize eye health and seek treatment for common symptoms.
A new treatment, telitacicept, shows promise in reducing kidney damage in IgA nephropathy.
The prefilled syringes market is rapidly growing, offering easier access to important medications for chronic conditions.
Adding Renuvion to liposuction boosts satisfaction and reduces follow-up surgeries.
Aquablation therapy is now recommended for more men with prostate issues, offering long-lasting urinary symptom relief.
Humana will cover Barostim therapy for heart failure patients, improving access to this innovative treatment.
A new oral drug, FT2109, shows promise in treating inflammation with fewer side effects than current options.
New data on cancer therapies could improve treatment options for patients.
A new immunotherapy for prostate cancer, Bria-PROS+, is set to enter clinical trials, aiming to enhance immune responses against tumors.
A symposium on muscle biology will explore new treatments for muscle-related diseases, which may enhance health as we age.
A free online event offers caregivers tips to enhance communication with loved ones with dementia.
Research suggests glutamine may help keep muscle stem cells active in aging.
Research shows that lower ULK1 levels are linked to faster cognitive decline in Alzheimer’s patients.
A new drug may reduce the treatment burden for wet AMD patients.
A new treatment for depression shows promising early results, potentially helping those who haven’t responded to other therapies.
Lilly and UNICEF are working together to improve health for children in poorer countries by tackling diseases that can affect them for life.
A new nasal treatment may reduce brain inflammation in Multiple System Atrophy patients.
A new study shows diranersen may reduce tau levels and improve cognitive function in early Alzheimer’s patients.
Physical activity is linked to lower biological age, but the connection isn't strong or fully understood yet.
Social living may boost lifespan, suggesting that relationships are key to healthy aging.
A new trial is testing solengepras to help manage Parkinson's symptoms.
A new gene therapy shows promise in reducing tau protein linked to cognitive decline.